ImClone Investigational Site

Memphis, Tennessee 38120

0 studies enrolling now · 6 studies all time

What they study most

Adenocarcinoma, Breast Cancer, Colorectal Cancer, Colorectal Neoplasms, Gastric Cancer, Non Small Cell Lung Cancer, Sarcoma, Soft Tissue

Studies at this site

• First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin — Completed
• Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer — Completed
• Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma — Completed
• A Study of Olaratumab in Soft Tissue Sarcoma — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed
• A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer — Completed